Aurobindo Pharma is launching its first share buyback in two years, offering to repurchase over 54 lakh shares at Rs 1,475 each. This tender offer, open to shareholders as of April 16, represents a significant move for the pharmaceutical giant. The company’s stock has shown resilience, gaining ground despite broader market declines.